One in three South Korean COVID-19 patients improve with remdesivir – Reuters

SEOUL (Reuters) – One in three South Korean patients seriously ill with COVID-19 showed an enhancement in their condition after being provided Gilead Sciences Incs (GILD.O) antiviral remdesivir, health … [+1644 chars]